Investment Rating - The report maintains an "Overweight" rating for the consumer discretionary and commercial trade sectors [7] Core Insights - The performance of leading overseas beauty and luxury brands in China has shown a continued recovery since Q3 2025, with significant revenue growth reported in Q4 2025 [1][2] - The overall sentiment indicates a strong recovery in high-end consumer spending in mainland China, driven by improved consumer confidence in luxury and medical beauty products [1][2] Summary by Sections Industry Overview - Leading brands such as Estée Lauder and L'Oréal have reported increased revenue contributions from the China market, with Estée Lauder's revenue share rising from 15% in Q3 2025 to 22% in Q4 2025 [1] - L'Oréal noted a recovery in revenue growth rates in mainland China, moving from low single digits in H1 2025 to mid-single digits in H2 2025 [2] Regional Performance - Revenue growth in the China region has accelerated, with Estée Lauder's growth rate increasing from 9% in Q3 2025 to 13% in Q4 2025 [2] - The Asia-Pacific region has shown a consistent improvement in revenue trends, with LVMH's revenue growth in the region gradually recovering from -11% to +1% over the four quarters of 2025 [2] Channel Insights - Travel retail has shown signs of recovery, with airport traffic in North Asia returning to pre-pandemic levels [3] - E-commerce channels have performed steadily, with Shiseido reporting mid-single-digit growth in Q4 2025 [3] - High-end brands have seen improved performance in offline channels, with Estée Lauder reporting an increase in market share in the Chinese market [3] Category Performance - High-end skincare and makeup categories have performed exceptionally well, with Shiseido's key brands showing strong revenue growth in Q4 2025 [4] - Medical aesthetics have also seen robust growth, with significant year-over-year increases reported in various product categories [4] Future Outlook - Some leading brands have adjusted their performance guidance positively, with Estée Lauder raising its FY26 revenue growth forecast to 3%-5% [5] - Procter & Gamble has maintained its FY26 guidance, anticipating stronger growth in the second half of FY26 [5]